跳至主要内容
临床试验/NCT01869842
NCT01869842Unknown不适用

Randomized Controlled Study of the Traditional Percutaneous Coronary Intervention and Intervention Using Optical Coherence Tomography of Incomplete Stent Adhesion and Extent of the Formation of Neointima by Resolute Zotarolimus-eluting Stent Insertion

Yonsei University1 个研究点 分布在 1 个国家目标入组 115 人开始时间: 2011年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
115
试验地点
1
主要终点
ratio of the stent strut

研究概览

简要总结

Optical coherence tomography (OCT) after the stent procedure to improve the adhesion and expansion, or incomplete uncovered struts attached to the main track. OCT in clinical areas by improving the parameters of the best stent will be useful. However, for better results for optical coherence tomography in percutaneous interventions have little useful data on the role. Randomized controlled study of the traditional percutaneous coronary intervention and intervention using optical coherence tomography.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Single lesion in a Single vessel
  • •Reference vessel diameter 2.5 - 3.5 mm
  • •Lesion length ≤ 34 mm and ≤ 34 mm stent length
  • •Stable angina requiring revascularization, patients with unstable angina
  • •The patient has no difficulty to enforce the follow-up angiography
  • •Patient is ≥ 20 years old

排除标准

  • •Lesions with graft vessel, thrombosis, restenosis, and bifurcation requiring 2 stents
  • •Reference vessel diameter < 2.5 mm or > 4.0mm
  • •Contraindication to anti-platelet agents
  • •Treated with any DES within 3 months at other vessel
  • •Creatinine level ≥ 2.0 mg/dL or ESRD
  • •Severe hepatic dysfunction (3 times normal reference values)
  • •Patients with LVEF < 30%
  • •Life expectancy 1 year
  • •Lesions with CTO or left main
  • •Target vessel of ST-elevation MI
  • •Lesions requiring overlapped stenting or more than 2 DES in each vessel
  • •Heavy calcified lesions (definite calcified lesions on angiogram)
  • •Far distal or tortuous lesions having difficulties in OCT evaluation or follow-up OCT
  • •Pregnant women or women with potential childbearing

研究组 & 干预措施

DM, angio group

Active Comparator

干预措施: percutaneous coronary intervention (Procedure)

DM, OCT group

Experimental

干预措施: OCT-guided percutaneous coronary intervention (Procedure)

non DM, angio group

Active Comparator

干预措施: percutaneous coronary intervention (Procedure)

non DM, OCT group

Experimental

干预措施: OCT-guided percutaneous coronary intervention (Procedure)

结局指标

主要结局

ratio of the stent strut

时间窗: Angiographic follow-up with OCT at 6 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验